Quantitative Imaging Biomarkers Alliance (QIBA) Meeting Hyatt Regency O’Hare May 25-26, 2010 RSNA would like to acknowledge the National Institute of Biomedical Imaging and Bioengineering for its partial financial support of the 2010 QIBA Meeting Presentations
	Day I: Tuesday, May 25, 2010
	8:30 AM		Welcome/Logistics	Daniel Sullivan, MD Linda Bresolin, PhD, MBA, CAE
	8:40 AM		Summary of QIBA Goals, Progress, Current Status	Daniel Sullivan, MD
	8:50 AM		FDA Perspective on Qualification of Biomarkers	Federico Goodsaid, PhD (by telephone)
	9:10 AM		Discussion and Q&A Session
	9:30 AM		Status of Regulatory Interactions	Andrew Buckler, MS
	9:40 AM		Status of QIBA Profiles	Kevin O’Donnell
	9:50 AM		UPICT / QIBA Relationship	Gary Dorfman, MD
	10:30 AM		Industry Panel Comments
	10:50 AM		CT Committee Update	Lawrence Schwartz, MD
	11:00 AM		COPD Committee Update	Philip Judy, PhD
	11:10 AM		PET Committee Update	Paul Kinahan, PhD
	11:20 AM		MR Committee Update	Gudrun Zahlmann, PhD
	11:30 AM		fMRI Committee Update	Jeffrey Petrella, MD
	11:40 AM		Q&A Session
	12:30 PM		Ad Hoc Committee on Open Image Archives	Gudrun Zahlmann, PhD Rick Avila, MS
	12:45 PM		Discussion
	1:00-5:00 PM		Individual Committee Sessions CT Committee COPD Committee PET Committee MR Committee fMRI Committee
	Day II: Wednesday, May 26, 2010
	8:00 AM		Individual Committee Sessions continue
	10:20 AM		Committee Reports
	10:20 AM		fMRI Committee Report	Jeffrey Petrella, MD
	10:40 AM		MR Committee Report	Gudrun Zahlmann, PhD
	11:00 AM		PET Committee Report	Richard A. Frank, MD, PhD
	11:20 AM		COPD Committee Report	David A. Lynch, MB
	11:40 AM		CT Committee Report	Andrew Buckler, MS Kevin O’Donnell
	12:00 PM		Q&A Session
	12:30 PM		Discussion Topics to include: · Sustainability · Interactions with clinical trial groups; FNIH; QIN · Publicity; “Roadshows”
	2:30 PM		Next Steps
	2:45 PM		Adjourn